 |
Previous Article | Next Article 
The Journal of Neuroscience, April 15, 2002, 22(8):3061-3069
ADP and AMP Induce Interleukin-1 Release from Microglial Cells
through Activation of ATP-Primed P2X7 Receptor Channels
Yassar
Chakfe1,
Rosanne
Seguin2,
Jack P.
Antel2,
Céline
Morissette3,
Danielle
Malo4,
Duncan
Henderson5, and
Philippe
Séguéla1
1 Cell Biology of Excitable Tissue Group and
2 Neuroimmunology Unit, Montreal Neurological Institute,
Montreal, Quebec, Canada H3A 2B4, 3 Department of Biology,
Neurochem Inc., Saint-Laurent, Quebec, Canada H4S 2A1,
4 Department of Medicine and Human Genetics, McGill
University, Montreal, Quebec, Canada H3G 1A4, and
5 Department of Molecular Biology, AstraZeneca Charnwood,
Loughborough, United Kingdom LE11 5RH
P2X7 is a subtype of ATP-gated channels that is highly
expressed in astrocytes, microglia, and other immune cells. Activation of P2X7 purinoceptors by ATP or
3'-O-(4-benzoyl)-benzoyl ATP (BzATP) induces the
formation of cytolytic pores and provokes release of interleukin-1
from immune cells. We investigated the actions of other endogenous
nucleotides on recombinant and microglial P2X7 receptors
using electrophysiology, fluorescence imaging, and interleukin-1
release measurement. We found that initial application of ADP or AMP to
Xenopus oocytes expressing P2X7 receptors was ineffective. However, when ADP and AMP, but not UTP or adenosine, were applied after a brief exposure to ATP or BzATP, they activated P2X7 receptors in a dose-dependent manner. Moreover,
responses to ADP and AMP were also elicited after exposure to low
concentrations of ATP and were recorded several minutes after removal
of ATP from the extracellular medium. Whole-cell recordings from mouse microglial cells showed that significant responses to ADP and AMP were
elicited only after ATP application. YO-PRO-1 dye uptake imaging
revealed that, unlike ATP, prolonged application of ADP or AMP did not
cause an opening of large cytolytic pores in mouse microglial cells.
Finally, ADP and AMP stimulated the release of interleukin-1 from
ATP-primed mouse and human microglial cells. We conclude that selective
sensitization of P2X7 receptors to ADP and AMP requires
priming with ATP. This novel property of P2X7 leads to
activation by ATP metabolites and proinflammatory cytokine release from
microglia without cytotoxicity.
Key words:
nucleotides; purinoceptors; interleukin-1 ; cytokines; pore formation; microglia
Copyright © 2002 Society for Neuroscience 0270-6474/02/2283061-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
S. D. Skaper, P. Debetto, and P. Giusti
The P2X7 purinergic receptor: from physiology to neurological disorders
FASEB J,
February 1, 2010;
24(2):
337 - 345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Gourine, N. Dale, E. Llaudet, D. M. Poputnikov, K. M. Spyer, and V. N. Gourine
Release of ATP in the central nervous system during systemic inflammation: real-time measurement in the hypothalamus of conscious rabbits
J. Physiol.,
November 15, 2007;
585(1):
305 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Stock, T. Schilling, A. Schwab, and C. Eder
Lysophosphatidylcholine Stimulates IL-1beta Release from Microglia via a P2X7 Receptor-Independent Mechanism
J. Immunol.,
December 15, 2006;
177(12):
8560 - 8568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Honore, D. Donnelly-Roberts, M. T. Namovic, G. Hsieh, C. Z. Zhu, J. P. Mikusa, G. Hernandez, C. Zhong, D. M. Gauvin, P. Chandran, et al.
A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat
J. Pharmacol. Exp. Ther.,
December 1, 2006;
319(3):
1376 - 1385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Yeung, K. Zablocki, C.-F. Lien, T. Jiang, S. Arkle, W. Brutkowski, J. Brown, H. Lochmuller, J. Simon, E. A. Barnard, et al.
Increased susceptibility to ATP via alteration of P2X receptor function in dystrophic mdx mouse muscle cells
FASEB J,
April 1, 2006;
20(6):
610 - 620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ferrari, C. Pizzirani, E. Adinolfi, R. M. Lemoli, A. Curti, M. Idzko, E. Panther, and F. Di Virgilio
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
J. Immunol.,
April 1, 2006;
176(7):
3877 - 3883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kawamura, F. Aswad, M. Minagawa, S. Govindarajan, and G. Dennert
P2X7 Receptors Regulate NKT Cells in Autoimmune Hepatitis
J. Immunol.,
February 15, 2006;
176(4):
2152 - 2160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Geary, H. Akinbi, T. Korfhagen, J.-E. Fabre, R. Boucher, and W. Rice
Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa
Am J Physiol Lung Cell Mol Physiol,
November 1, 2005;
289(5):
L890 - L895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Aswad, H. Kawamura, and G. Dennert
High Sensitivity of CD4+CD25+ Regulatory T Cells to Extracellular Metabolites Nicotinamide Adenine Dinucleotide and ATP: A Role for P2X7 Receptors
J. Immunol.,
September 1, 2005;
175(5):
3075 - 3083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kawamura, F. Aswad, M. Minagawa, K. Malone, H. Kaslow, F. Koch-Nolte, W. H. Schott, E. H. Leiter, and G. Dennert
P2X7 Receptor-Dependent and -Independent T Cell Death Is Induced by Nicotinamide Adenine Dinucleotide
J. Immunol.,
February 15, 2005;
174(4):
1971 - 1979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Solini, P. Chiozzi, A. Morelli, E. Adinolfi, R. Rizzo, O. R. Baricordi, and F. Di Virgilio
Enhanced P2X7 Activity in Human Fibroblasts From Diabetic Patients: A Possible Pathogenetic Mechanism for Vascular Damage in Diabetes
Arterioscler Thromb Vasc Biol,
July 1, 2004;
24(7):
1240 - 1245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Raouf, Y. Chakfe, D. Blais, A. Speelman, E. Boue-Grabot, D. Henderson, and P. Seguela
Selective Knock-Down of P2X7 ATP Receptor Function by Dominant-Negative Subunits
Mol. Pharmacol.,
March 1, 2004;
65(3):
646 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Babcock, W. A. Kuziel, S. Rivest, and T. Owens
Chemokine Expression by Glial Cells Directs Leukocytes to Sites of Axonal Injury in the CNS
J. Neurosci.,
August 27, 2003;
23(21):
7922 - 7930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Milligan, C. Twining, M. Chacur, J. Biedenkapp, K. O'Connor, S. Poole, K. Tracey, D. Martin, S. F. Maier, and L. R. Watkins
Spinal Glia and Proinflammatory Cytokines Mediate Mirror-Image Neuropathic Pain in Rats
J. Neurosci.,
February 1, 2003;
23(3):
1026 - 1040.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|